DOTmed.com - Access Scientific Gets FDA Clearance for 4Fr Nanopuncture POWERWAND
SEARCH
Current Location:
>
> This Story

Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More News Headlines

CHIME and KLAS Formalize Partnership Agreement Release Top 10 Trends of 2014 Report for CIOs

Cytokinetics and Astellas Announce Expansion of Collaboration for Development of CK-2127107 in Spinal Muscular Atrophy and Other Cytokinetics Expects to Receive Over $75 Million in Committed Capital and Reimbursements For Planned Activities Companies Plan to Initiate Phase II Clinical Trial in 2015

Inogen Announces Reimbursement for the Inogen One G3 in Germany The Second Largest Market in Europe to Improve Access to Inogen Technology

Medtronic Drug-Coated Balloon for Peripheral Artery Disease Tops Standard Balloon Angioplasty in Landmark Study Results of IN.PACT SFA Trial Published in Circulation

Aesculap, Inc. Launches Online Surgical Asset Management Resource Center for Central Service Professionals New Educational Website Provides Central Service Professionals With Sterile Processing Tools and Resources

Carestream Health is First Company To Receive U.S. Navy Certification to Implement Medical Image Management Systems Company's PACS Passes Strict DIACAP Security Tests; Its Systems Enable Multi-Site Reading and Sharing of Medical Images, Information with Physicians

Lupus Miliaris Disseminatus Faciei Treated With 1,565nm Nonablative Fractionated Laser Resurfacing: A Case Report

IRADIMED CORPORATION Resumes Domestic Distribution of Infusion Pumps

Australian presence of Elekta's Versa HD radiation therapy system grows Two centers treating patients, one preparing for clinical start-up

Meridian Health Joins Cerner to Aggregate Population Health Data Across Multiple EHRs Meridian to Implement Cerner HealtheIntent-Based Solutions Across More Than 100 New Jersey Facilities

Access Scientific Gets FDA Clearance for 4Fr Nanopuncture POWERWAND

Newly Improved Peripheral IV Catheter Is Blood-Drawable, Power-Injectable, and Can Deliver Therapy for Entire Length of Stay

SAN DIEGO -- Access Scientific, Inc. announced it has received FDA 510(k) clearance for the 4Fr Nanopuncture™ POWERWAND®. The unique peripheral IV catheter (technically a midline at 3.1 inches) is lighter and designed to provide smoother handling and even greater ease of insertion.

Story Continues Below Advertisement

ENTERPRISE LEVEL INFORMATION SHARING - register for a demo

McKesson Enterprise Medical Imaging Solutions deliver what you need to stay connected and help ensure that patient information is in the right place at the right time and easily accessible by all members of the care team.



The 4Fr Nanopuncture POWERWAND is, like the previously FDA-cleared 5Fr version, a power-injectable, peripheral IV catheter that is inserted using the proprietary Accelerated Seldinger Technique.

The POWERWAND can be used both for the administration of fluids/medications and for withdrawing blood for diagnostic tests. It is the first and only power-injectable peripheral IV (PIV) catheter capable of delivering continuous IV therapy for the patient's entire length of hospital stay. The device may be left in place for up to 29 days per its FDA clearance. It is also designed to be an integral part of any program to reduce central-line associated bloodstream infections (CLABSI).

The catheter has been well received by hospitals using it. "The 4Fr version gives the vascular access team more options. An extended-dwell catheter that can be placed both in the upper arm with ultrasound, or in the lower arm or forearm without using ultrasound, is the bridge we needed between the peripheral IV and the PICC. Sometimes with vascular access we need as many options as we can get," said Peter Hobday, RN, CCRN, CRNI, Director of the Vascular Access team at Brotman Medical Center, in Culver City, Calif.

The POWERWAND's versatility makes it the first and best choice for many patients, said Steve Bierman, M.D., president and CEO of Access Scientific.

"CDC Guidelines now say that patients whose IV therapy will likely exceed six days should have a midline or, if -- and only if - indicated, a central line," Dr. Bierman said. "Based on recent studies, this means that nearly 30% of hospitalized patients should have a POWERWAND."

In addition to allowing consistent blood draws, the catheter has a flow rate of 130 mL per minute -- making it by far the fastest-flowing peripheral line of its size. "This rapid flow rate capability translates into lives saved in the emergency department, OR and ICU," said Dr. Bierman.

The POWERWAND has several notable safety features:

* Alternative to central lines. Because it is not a central line, the catheter does not carry the same high risk of potentially fatal bloodstream infections. Midline catheters such as the 4Fr Nanopuncture POWERWAND have the lowest published bloodstream infection rate of all inpatient vascular access devices.

Continue reading Access Scientific Gets FDA Clearance for 4Fr Nanopuncture POWERWAND...
  Pages: 1 - 2 >>

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Center
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED